METHOD FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

AR135550A1Pending Publication Date: 2026-09-30ALEBUND PHARM (HONG KONG) LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ARP20250100774
Authority / Receiving Office: AR · AR
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-03-26
Filing Date: 2025-03-25
Publication Date: 2026-09-30

Application Information

Patent Timeline

26 Mar 2024

Priority

25 Mar 2025

Application

ARP20250100774

30 Sep 2026

Publication

AR135550A1

IPC: A61K31/421; A61K31/381; C07D263/22; A61P13/12

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.

Claims

This description relates to methods for treating autosomal dominant polycystic kidney disease (ADPKD). One method for treating autosomal dominant polycystic kidney disease (ADPKD) in an individual comprises administering to the individual a compound of formula (1).